- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Can Social Determinants of Health Predict High-Cost Utilizers Among the Commercially Insured Population?
On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the July 2023 issue of The American Journal of Managed Care® on whether social determinants of health is a predictor for identifying high-cost utilizers among those with commercial health insurance.
Elena Andreyeva, PhD, is an assistant professor at the Texas A&M University School of Public Health, and the lead author of the study, “Social Determinants of Health and High-Cost Utilization Among Commercially Insured Population.”
The study aimed to investiate the predictive properties of social determinants of health in identifying high-cost utilizers in the commercially insured population across various age groups.
Listen above or on one of these podcast services:
LLMs Show Promise, But Challenges Remain in Improving Inefficient Clinical Trial Screening
July 31st 2025Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
Read More
Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021
July 31st 2025Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.
Read More
